The Cancer Institute Administrative Office (AO) plays a crucial role in providing resources and efficient and effective administrative expertise to support the complex and expanding cancer basic and clinical research enterprise across the NYU Langone Medical Center. This includes administrative support to the Office of the Director, Associate Directors, Shared Resource Directors, Program Leaders, and NYUCI membership, as well as the investigators at the Cancer Research Center and the faculty in the Division of Hematology and Medical Oncology. The overarching goal for administration is to facilitate research and provide the infrastructure to move discoveries into the clinical setting. This is done through strategic planning and evaluation initiatives, business and financial planning for research programs and shared resources, development of policies and procedures for prudent financial and grants management for investigators at the Cancer Research Center and Division of Hematology and Medical Oncology, staffing of program meetings, scientific retreats, and seminars, supporting the submission of administratively demanding complex grants such as SPORE's and training grants, human resources, budget and finance, space, informatics, and facilities planning. The administrative team is responsible for all interactions across the NYU Langone Medical Center corporate offices (Grants Finance, Finance, IRB, Office of Clinical Trials, Office of Collaborative Sciences, Sponsored Programs Administration, Medical Center IT, and the Office of Communications). The AO provides services beyond the activities related to the CCSG such as fiscal management of clinical activities, auditing and oversight of clinical research billing compliance, the integration of clinical research operations throughout all clinical sites at the Cancer Institute, and academic and administrative oversight of the Division of Hematology and Medical Oncology and the Cancer Research Laboratories. The core mission of the CCSG defines and dictates the structure and decision-making processes within the administrative unit. There are eight major areas of focus for research administration: central CCSG administration, grants management, membership, shared resources, structure for inter- and intra-disciplinary collaborations, research program support, informatics, and financial management of the Cancer Institute. Support is requested for only those activities directly related to the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016087-34
Application #
8765192
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
34
Fiscal Year
2014
Total Cost
$63,019
Indirect Cost
$25,840
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Silvera, Deborah; Ernlund, Amanda; Arju, Rezina et al. (2017) mTORC1 and -2 Coordinate Transcriptional and Translational Reprogramming in Resistance to DNA Damage and Replicative Stress in Breast Cancer Cells. Mol Cell Biol 37:
Koh, Hyunwook; Blaser, Martin J; Li, Huilin (2017) A powerful microbiome-based association test and a microbial taxa discovery framework for comprehensive association mapping. Microbiome 5:45
Huang, Chao; Zeng, Xingruo; Jiang, Guosong et al. (2017) XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell. J Hematol Oncol 10:6
Morabito, Michael V; Ravussin, Yann; Mueller, Bridget R et al. (2017) Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain. PLoS One 12:e0168226
Koetz-Ploch, Lisa; Hanniford, Douglas; Dolgalev, Igor et al. (2017) MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway. Pigment Cell Melanoma Res 30:328-338
Ma, Lijie; Liu, Yan; Landry, Nichole K et al. (2017) Point mutation in D8C domain of Tamm-Horsfall protein/uromodulin in transgenic mice causes progressive renal damage and hyperuricemia. PLoS One 12:e0186769
Ono, Kentaro; Viet, Chi T; Ye, Yi et al. (2017) Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling. Sci Rep 7:9181
Wang, Xing; Zhang, Fenglin; Wu, Xue-Ru (2017) Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin. Sci Rep 7:45983
Feig, Jessica L; Mediero, Aranzazu; Corciulo, Carmen et al. (2017) The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin. PLoS One 12:e0188135
Tetz, George V; Ruggles, Kelly V; Zhou, Hua et al. (2017) Bacteriophages as potential new mammalian pathogens. Sci Rep 7:7043

Showing the most recent 10 out of 1082 publications